XML 83 R70.htm IDEA: XBRL DOCUMENT v3.22.1
Noncontrolling Interest (Details Narrative) - USD ($)
12 Months Ended
Oct. 14, 2021
Oct. 13, 2021
Dec. 31, 2021
Dec. 31, 2020
Noncontrolling Interest [Line Items]        
Common stock shares issued     86,367,845 63,819,935
Common stock, shares outstanding     86,367,845 63,819,935
Face value principal amount       $ 12,817,000
Proceeds from Issuance of Common Stock     $ 55,016,000 $ 16,032,000
IPO [Member]        
Noncontrolling Interest [Line Items]        
Stock Issued During Period, Shares, New Issues 571,428      
Lucid Diagnostics Inc [Member] | IPO [Member]        
Noncontrolling Interest [Line Items]        
Stock Issued During Period, Shares, New Issues 5,000,000.0      
Lucid Diagnostics Inc [Member] | IPO [Member] | Parent Company [Member]        
Noncontrolling Interest [Line Items]        
Stock Issued During Period, Shares, New Issues 571,428      
Sale of Stock, Price Per Share $ 14.00      
Proceeds from Issuance of Common Stock $ 70,000,000.0      
[custom:UnderwritingFees] 4,900,000      
Debt Issuance Costs, Net $ 700,000      
Lucid Diagnostics Inc [Member] | Senior Unsecured Promissory Note [Member]        
Noncontrolling Interest [Line Items]        
Debt Conversion, Converted Instrument, Shares Issued   15,803,200    
Debt conversion amount   $ 22,400,000    
Face value principal amount   $ 22,400,000    
Debt Instrument, Interest Rate, Stated Percentage   7.875%    
Maturity date   May 18, 2028    
Notes payable   $ 22,400,000    
Debt instrument convertible conversion   $ 1.42    
Veris Health Inc [Member]        
Noncontrolling Interest [Line Items]        
Common stock shares issued     8,000,000  
Veris Health Inc [Member] | Unrelated Third Parties [Member]        
Noncontrolling Interest [Line Items]        
Investment ownership percentage     19.56%  
Veris Health Inc [Member] | Parent Company [Member]        
Noncontrolling Interest [Line Items]        
Investment ownership percentage     80.44%  
Solys Diagnostics Inc [Member]        
Noncontrolling Interest [Line Items]        
Common stock shares issued     9,189,190 9,189,190
Solys Diagnostics Inc [Member] | Unrelated Third Parties [Member]        
Noncontrolling Interest [Line Items]        
Investment ownership percentage     9.6765% 9.6765%
Solys Diagnostics Inc [Member] | Parent Company [Member]        
Noncontrolling Interest [Line Items]        
Investment ownership percentage     90.3235% 90.3235%
Lucid Diagnostics Inc [Member]        
Noncontrolling Interest [Line Items]        
Common stock shares issued     34,917,907  
Common stock, shares outstanding     34,917,907  
Ownership equity interest     $ 27,927,190